16 May 2019 --- Glucosamine is used widely in joint health supplements to relieve osteoarthritis and joint pain, but it may also lower a person’s risk of cardiovascular disease (CVD). Published in The British Medical Journal (BMJ), these findings are based on a survey of nearly half a million British people. The avenue of research is certainly worth exploring, but controlled clinical trials are ultimately needed to establish cause and effect, notes Dr. Sonya Babu-Narayan, Associate Medical Director at the British Heart Foundation (BHF).